Fiera Capital (Canada)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,842
Closed -$247K 694
2016
Q4
$247K Hold
3,842
﹤0.01% 712
2016
Q3
$248K Sell
3,842
-1,607
-29% -$90.6K ﹤0.01% 669
2016
Q2
$302K Buy
+5,449
New +$274K ﹤0.01% 694

Other funds holding LKFT

Fiera Capital (Canada)'s LKFT Position: Q1 2017 in Review

Fiera Capital (Canada) sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2017, closing a stake of 3,842 shares — an estimated $247K sold.

Fiera Capital (Canada) first reported a position in LKFT in Q2 2016 and held it in 3 quarters. The position peaked at $302K in Q2 2016. 64 funds tracked by Wall St. Rank hold LKFT as of Q1 2017.

  • Fiera Capital (Canada) reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 3,842 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2017, an estimated $247K.
  • Fiera Capital (Canada) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2016 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Lakefront Biotherapeutics American Depositary Shares position peaked at $302K in Q2 2016.
  • 64 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.